Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marc Hautekeete is active.

Publication


Featured researches published by Marc Hautekeete.


Gastroenterology | 1999

HLA association of amoxicillin-clavulanate--induced hepatitis.

Marc Hautekeete; Yves Horsmans; C Van Waeyenberge; C. Demanet; Jean Henrion; L. Verbist; R. Brenard; Christine Sempoux; Peter P. Michielsen; P S Yap; Jacques Rahier; André Geubel

BACKGROUND & AIMS Drug-induced immunoallergic hepatitis typically affects a minority of patients exposed to a particular drug. Its rarity is believed to be due to metabolic or immunologic idiosyncrasy. The presence of an immunologic idiosyncrasy might imply an HLA association. Previous studies reporting an HLA association of drug-induced hepatitis included only small numbers of patients and used serological HLA typing. METHODS We studied 35 patients with biopsy-documented amoxicillin-clavulanate-induced hepatitis. HLA-A and -B were typed using alloantisera and compared with those of 300 controls (volunteer bone marrow donors). HLA-DRB and -DWB were typed by polymerase chain reaction-line probe assay, with 60 volunteer bone marrow donors serving as controls. RESULTS The study group was characterized by a higher frequency of DRB1*1501-DRB5*0101-DQB1*0602 haplotype (57.1% vs. 11.7% in controls, P < 0.000005; after correction for the large number of comparisons, P < 0.0002). Patients with DRB1*1501-DRB5*0101-DQB1*0602 haplotype were more likely than patients without it to have a cholestatic (70% vs. 60%) or mixed (30% vs. 13%) than a hepatocellular pattern of hepatitis (0% vs. 27%) (P < 0.05). CONCLUSIONS Amoxicillin-clavulanate-induced hepatitis is associated with the DRB1*1501-DRB5*0101-DQB1*0602 haplotype. The data support the view that an immunologic idiosyncrasy, mediated through HLA class II antigens, plays a role in the pathogenesis of drug-induced immunoallergic hepatitis. HLA association has a limited impact on the expression of hepatitis.


Journal of Hepatology | 1995

Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations

Marc Hautekeete; R. Brenard; Yves Horsmans; Jean Henrion; Louis Verbist; Geneviève Derue; P. Druez; Mohamed Omar; Marc M. Kockx; Hubert Hubens; Israel Haber; Jacques Rahier; André Geubel

We report eight cases of liver injury related to amoxycillin-clavulanate. Liver biopsy performed in seven patients revealed varying degrees of injury to interlobular bile ducts in all cases. Lesions included irregularity of the nuclei, vacuolization of the cytoplasm, lymphocytic infiltration, destruction and endothelialization of the bile duct epithelium. Ductopenia was not observed. In two patients liver injury was accompanied by prominent extrahepatic manifestations (acute interstitial nephritis in one and acute lacrimal gland inflammation and sialadenitis with prolonged xerostomia in the other). We conclude that interlobular bile-duct lesions of varying severity are a common feature in liver injury related to amoxycillin-clavulanate. Side effects of the drug include acute interstitial nephritis and sialadenitis.


Journal of Hepatology | 1998

Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients

Johannes T. Brouwer; Frederik Nevens; Bernhard Kleter; André Elewaut; Michael Alder; R. Brenard; Robert A.E.M. Chamuleau; Peter P. Michielsen; Jean Pirotte; Marc Hautekeete; Joseph Weber; Nadine Bourgeois; Bettina E. Hansen; Cm Bronkhorst; Fibo ten Kate; Rudolf A. Heijtink; Johan Fevery; Solko W. Schalm

BACKGROUND/AIMS In an attempt to improve the limited efficacy of treatment of chronic hepatitis C with interferon-alpha 3 MU tiw, we studied the effects of double-dose therapy followed by downward titration, and analyzed the pre- and pertreatment factors associated with response or non-response. METHODS Three hundred and fifty-four consecutive patients in 19 centers were randomized to interferon-alpha 3 MU tiw for 6 months or 6 MU tiw for 8 weeks followed by down-titration (3,1 MU tiw) till alanine aminotransferase remained normal and plasma HCV RNA was repeatedly undetectable. The primary outcome measure was sustained alanine aminotransferase and HCV RNA response 6 months after treatment. RESULTS Three hundred and thirty-six patients received treatment. The sustained response rate for patients receiving 3 MU tiw for 6 months was 14% (9-21%,) and for patients receiving double dose tiw for 8 weeks and thereafter titrated therapy 15% (10-21%) (p=0.8). Pretreatment factors associated with a sustained alanine aminotransferase plus HCV RNA response were the absence of cirrhosis, presence of genotype 2 or 3, a low viral load and, in addition, a low alanine aminotransferase/aspartate aminotransferase ratio; a model was developed to allow estimation of the chance of response for the individual patient. The most powerful predictor of sustained response, however, was plasma HCV RNA at week 4; a positive test virtually precluded a sustained response (1.7%, 0.4-5.0%). If week 4 HCV RNA was not detectable, the chance of a sustained response was 21% (12-34%) for genotype 1 versus 40% (28-54%) for the others (p=0.02). Six MU tiw led to a significantly higher week 4 HCV RNA response (47% not detectable) than 3 MU (37%) (p=0.02). During down-titration this difference in viral on-treatment response was lost. CONCLUSIONS In the treatment of hepatitis C, an early HCV RNA response is a prerequisite for long-term efficacy. Doubling the initial interferon dose increases this early response, but subsequent downward titration negates this effect, especially in genotype 1.


Digestive Diseases and Sciences | 1994

Duodenal diaphragmlike stricture induced by acetylsalicylic acid

Georges H. Blinder; Marc Hautekeete; Joannes P. Holvoet; Marc M. Kockx; Hubert Hubens

SummaryMany reports have mentioned the role of nonsteroidal antiinflammatory drugs in inducing diaphragmlike strictures in the small and large bowel. These lesions are mostly seen in patients with chronic use of nonsteroidal antiinflammatory drugs. We report the case of a 57-year-old man who developed a diaphragmlike stricture in the second part of the duodenum. The patient had been using a preparation containing acetylsalicylic acid during many years. Although a congenital origin of the diaphragm is not completely excluded, we postulate that this stricture probably occurred as a result of acetylsalicylic acid-induced ulcerations, followed by submucosal fibrosis.


Schizophrenia Research | 1997

High prevalence of Helicobacter pylori in institutionalized schizophrenic patients.

M. De Hert; Marc Hautekeete; D De Wilde; Joseph Peuskens

gender. Schizophrenic patients were diagnosed Gastroscopic lesions 0% 22% 29% according to DSM-IV-criteria (Table 1). The cohort of patients was divided into three groups according to life-time length of stay: 5 years. The presence hospital for the schizophrenic patients. The seroof Helicobacter pylori was assessed by means of an prevalence increased with length of stay in instituenzyme-linked immunosorbent assay (Malakit, tions and reached a plateau at 38% after five years Biolab; Blecker et al., 1993). Controls were healthy of stay. volunteer blood donors. Our study shows a high prevalence of We found significant dierences between Helicobacter pylori in institutionalized schizopatients and controls on prevalence of Helicobacter phrenic patients. Transmission occurs in the first pylori (34.8% vs. 14.6%, p<0.01) with an Odds years of stay in institutions. Our study supports the Ratio of 3.0 (95% confidence interval 1.4‐7.3). hypothesis of person-to-person transmission of There was a strong correlation between the preva- Helicobacter pylori. Other sources of infection such lence of Helicobacter pylori and length of stay in as food were unlikely because parts of the life-time stay of the patients occurred in dierent hospitals. * Corresponding author.


Journal of Clinical Gastroenterology | 1990

Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in a Caribbean patient.

Marc Hautekeete; R. Brenard; Antoine Hadengue; Claude Degott; Gérard Babany; Lionel Arrivé; Didier Lebrec; Yves Menu; Serge Erlinger; Jean-Pierre Benhamou

Membranous obstruction of the inferior vena cava has been reported mainly in South Africa, Japan, and India; in 20-40% of patients the disease is complicated by hepatocellular carcinoma. We report a case of membranous obstruction of the inferior vena cava with hepatocellular carcinoma in a 43-year-old Caribbean man of Indian origin. The Caribbean islands may constitute another geographical area where the population is at risk for the development of membranous obstruction of the inferior vena cava and subsequent hepatocellular carcinoma.


Liver | 1999

Remission of autoimmune hepatitis during pregnancy: a report of two cases

Isabelle Colle; Marc Hautekeete


Gastroenterologie Clinique Et Biologique | 1998

Symptomatic liver injury probably related to sertraline.

Marc Hautekeete; I. Colle; van Vlierberghe H; André Elewaut


Journal of Clinical Gastroenterology | 1999

Granulomatous hepatitis due to mebendazole

Isabelle Colle; Serge Naegels; Anne Hoorens; Marc Hautekeete


Nucleic Acids Research | 1998

Hepatitis C virus genotypes: epidemiological and clinical associations

Bernhard Kleter; Johannes T. Brouwer; Frederik Nevens; Doorn van L. J; André Elewaut; Jacques Versieck; Peter P. Michielsen; Marc Hautekeete; Robert A. F. M. Chamuleau; R. Brenard; Nadine Bourgeois; Michael Adler; Wim Quint; Cm Bronkhorst; R.A. Heijtink; W. J. C. Hop; Johan Fevery; Solko W. Schalm

Collaboration


Dive into the Marc Hautekeete's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jacques Rahier

Cliniques Universitaires Saint-Luc

View shared research outputs
Top Co-Authors

Avatar

André Geubel

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yves Horsmans

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. De Hert

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Michael Adler

Université libre de Bruxelles

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joseph Peuskens

The Catholic University of America

View shared research outputs
Researchain Logo
Decentralizing Knowledge